{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T13:09:43Z","timestamp":1725714583696},"publisher-location":"Berlin, Heidelberg","reference-count":20,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642815676"},{"type":"electronic","value":"9783642815652"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1981]]},"DOI":"10.1007\/978-3-642-81565-2_5","type":"book-chapter","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T08:23:28Z","timestamp":1359534208000},"page":"41-60","source":"Crossref","is-referenced-by-count":1,"title":["Current Status of PEP Bleomycin Studies in Japan"],"prefix":"10.1007","author":[{"given":"S.","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Miyasato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5_CR1","first-page":"165","volume":"60","author":"RL Comis","year":"1976","unstructured":"Comis RL (1976) DTIC (NSC-45388) in malignant melanoma; a perspective. Cancer Treat Rep 60:165\u2013173","journal-title":"Cancer Treat Rep"},{"key":"5_CR2","first-page":"1273","volume":"60","author":"G Wasch De","year":"1976","unstructured":"De Wasch G, Bernheim J, Michel J, Lejeune F, Kenis Y (1976) Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma. Cancer Treat Rep 60:1273\u20131276","journal-title":"Cancer Treat Rep"},{"key":"5_CR3","first-page":"593","volume":"79","author":"K Higuchi","year":"1969","unstructured":"Higuchi K, Goto M, Kurita R (1969) Studies of bleomycin in dermatology (Clinical study). Jpn J Dermatol Ser A 79:593\u2013609","journal-title":"Jpn J Dermatol Ser A"},{"key":"5_CR4","first-page":"296","volume":"14","author":"T Ichikawa","year":"1968","unstructured":"Ichikawa T (1968) Introduction of bleomycin (BLM). Jpn J Cancer Clin 14:296","journal-title":"Jpn J Cancer Clin"},{"key":"5_CR5","first-page":"91","volume":"26","author":"T Ichikawa","year":"1978","unstructured":"Ichikawa T (1978) Basic and clinical studies of antitumor spectra of anticancer agents (4) with particular reference to bleomycin. Chemotherapy 26:91\u201396","journal-title":"Chemotherapy"},{"key":"5_CR6","first-page":"734","volume":"29","author":"S Ikeda","year":"1975","unstructured":"Ikeda S, Miyasato H, Imai K, Seki M, Nakayama H, Mori Y, Mizutani H (1975) Local chemotherapy of skin tumors (I) with particular reference to clinical application of bleomycin ointment. Jpn J Clin Dermatol 29:734\u2013478","journal-title":"Jpn J Clin Dermatol"},{"key":"5_CR7","first-page":"827","volume":"29","author":"S Ikeda","year":"1975","unstructured":"Ikeda S, Kawamura T, Miyasato H, Imai K, Nakayama H, Ishihara K, Mizutani H (1975) Local chemotherapy of skin tumors (II) basic study of bleomycin ointment. Jpn J Clin Dermatol 29:827\u2013839","journal-title":"Jpn J Clin Dermatol"},{"key":"5_CR8","first-page":"235","volume":"19","author":"S Ikeda","year":"1976","unstructured":"Ikeda S, Hamamatsu T, Ishihara K (1976) Effects of bleomycin on skin cancer. Gann 19:235\u2013250","journal-title":"Gann"},{"key":"5_CR9","first-page":"981","volume":"9","author":"S Ikeda","year":"1976","unstructured":"Ikeda S, Hamamatsu T, Tazima K, Miyasato H, Imai K, Nakayama H, Mizutani H (1976) Clinical trial of NK5033 in dermatology. Med Treat 9:981\u2013999","journal-title":"Med Treat"},{"key":"5_CR10","first-page":"1237","volume":"9","author":"S Ikeda","year":"1976","unstructured":"Ikeda S, Nakayama H, Hamamatsu T, Miyasato H, Imai K, Seki M (1976) Local oil BLM therapy in dermatology. Med Treat 9:1237\u20131254","journal-title":"Med Treat"},{"key":"5_CR11","first-page":"903","volume":"59","author":"S Ikeda","year":"1977","unstructured":"Ikeda S, Hamamatsu T, Miyasato H, Imai K, Nakayama H (1977) Skin cancer, a new therapy. J Ther 59:903\u2013920","journal-title":"J Ther"},{"key":"5_CR12","first-page":"384","volume":"14","author":"S Ikeda","year":"1979","unstructured":"Ikeda S, Miyasato H, Nakayama H, Kobayashi Y (1979) Clinical trial of pepleomycin in dermatology. J Jpn Soc Cancer Ther 14:384","journal-title":"J Jpn Soc Cancer Ther"},{"key":"5_CR13","first-page":"436","volume":"41","author":"Y Imamura","year":"1978","unstructured":"Imamura Y (1978) Immunoblastic lymphadenopathyconcept of disease and study of cases reported in Japan. Intern Med 41:436\u2013442","journal-title":"Intern Med"},{"key":"5_CR14","first-page":"1593","volume":"27","author":"K Kimura","year":"1969","unstructured":"Kimura K, Sakai Y, Konda C, Kashiwada N, Kitahara T, Inagaki H, Itano T, Fujita H, Izuka N, Mikuni N (1969) Chemotherapy of malignant lymphoma, with particular reference to bleomycin. Jpn J Clin Med 27:1593\u20131601","journal-title":"Jpn J Clin Med"},{"key":"5_CR15","first-page":"191","volume":"63","author":"A Matsuda","year":"1978","unstructured":"Matsuda A, Yoshioka O, Yamashita T, Ebihara K, Umezawa H, Murata T, Katayama K, Yokoyama M, Nagai S (1978) Fundamental and clinical studies on new bleomycin analogs. Recent Results Cancer Res 63:191\u2013210","journal-title":"Recent Results Cancer Res"},{"key":"5_CR16","first-page":"29","volume":"4","author":"H Miyasato","year":"1978","unstructured":"Miyasato H (1978) Two cases of oral florid papillomatosis treated by cryosurgery. J Cryosurg Res Group 4:29\u201330","journal-title":"J Cryosurg Res Group"},{"key":"5_CR17","first-page":"1271","volume":"28","author":"T Takita","year":"1977","unstructured":"Takita T (1977) Development of new drugs; chemical and biological modifications of bleomycin. Chem Ind 28:1271\u20131277","journal-title":"Chem Ind"},{"key":"5_CR18","first-page":"41","volume":"30","author":"W Tanaka","year":"1977","unstructured":"Tanaka W (1977) Development of new bleomycins with potential clinical utility. Jpn J Antibiot (Tokyo) [suppl] 30:41\u201348","journal-title":"Jpn J Antibiot (Tokyo) [suppl]"},{"key":"5_CR19","first-page":"1079","volume":"1965","author":"H Umezawa","year":"1965","unstructured":"Umezawa H (1965) Bleomycin and other antitumor antibiotics of high molecular weight. Antimicrob Agents Chemother 1965:1079\u20131085","journal-title":"Antimicrob Agents Chemother"},{"key":"5_CR20","first-page":"797","volume-title":"Cancer of the skin; vol 1","author":"K Wolff","year":"1976","unstructured":"Wolff K, Toppeiner J (1976) Oral florid papillomatosis. In: Andrade R, Gumport SL, Popkin GL, Rees TD (eds) Cancer of the skin; vol 1. Saunders, W. Washington Square, pp 797\u2013813"}],"container-title":["Recent Results in Cancer Research","New Drugs in Cancer Chemotherapy"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-81565-2_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T23:48:40Z","timestamp":1557532120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-81565-2_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981]]},"ISBN":["9783642815676","9783642815652"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-81565-2_5","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1981]]}}}